Compositions and methods for controlling insect pests
US-2017183683-A1 · Jun 29, 2017 · US
US10801028B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10801028-B2 |
| Application number | US-201715498008-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 26, 2017 |
| Priority date | Oct 14, 2009 |
| Publication date | Oct 13, 2020 |
| Grant date | Oct 13, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An isolated nucleic acid agent is disclosed comprising a nucleic acid sequence which downregulates expression of a gene product of a Varroa destructor mite. Compositions comprising same and uses thereof are also disclosed.
Opening claim text (preview).
What is claimed is: 1. A composition comprising at least one nucleic acid agent which comprises a nucleic acid sequence which downregulates expression of a gene product of a Varroa destructor mite, and wherein said nucleic acid agent does not comprise a permeation enhancing agent selected from the group consisting of a virus, a polyamine, a polycation, a lipopolyamine, an anionic lipid, a neutral lipid, a pH sensitive lipid, transferrin, biotin, a serum protein, a glycoprotein, polyethylene glycol, and a cationic lipid. 2. The composition of claim 1 , wherein said at least one nucleic acid agent comprises at least five nucleic acid agents, for down-regulating ATPase subunit A, RNA polymerase III, Inhibitor of apoptosis (IAP), FAS apoptotic inhibitor and α-Tubulin, each of said at least five nucleic acid agent targeting a different gene. 3. The composition of claim 1 , wherein said at least one nucleic acid agent comprises at least six nucleic acid agents, for down-regulating ATPase subunit A, RNA polymerase I, RNA polymerase III, Inhibitor of apoptosis (IAP), FAS apoptotic inhibitor and α-Tubulin, each of said at least six nucleic acid agents for targeting a different gene. 4. The composition of claim 2 , wherein said nucleic acid agents are as set forth in SEQ ID Nos: 1, 13, 27, 30 and 39. 5. The composition of claim 3 , wherein said nucleic acid agents are as set forth in SEQ ID Nos: 1, 4, 7, 10, 13, 16, 19, 22, 25, 27, 30, 33, 36 and 39. 6. The composition of claim 1 , wherein said composition is in solid form. 7. The composition of claim 1 , wherein said composition is in liquid form. 8. The composition of claim 1 , wherein said composition comprises protein. 9. The composition of claim 7 , wherein said liquid is a sucrose solution. 10. The composition of claim 7 , wherein said liquid is a corn syrup solution. 11. The composition of claim 7 , wherein said liquid further comprises a carbohydrate or sugar supplement. 12. The composition of claim 1 , wherein said nucleic acid sequence comprises a sequence complementary to at least 21 nucleotides of Varroa destructor mite messenger RNA (mRNA). 13. The composition of claim 12 , wherein said Varroa destructor mite mRNA encodes a polypeptide selected from the group consisting of ATPase subunit A, RNA polymerase III, IAP, FAS apoptotic inhibitor, and α-Tubulin. 14. The composition of claim 1 , wherein said nucleic acid sequence is greater than 15 base pairs in length. 15. The composition of claim 1 , wherein said nucleic acid sequence is greater than 19 to 25 base pairs in length. 16. The composition of claim 1 , wherein said nucleic acid sequence is greater than 30 base pairs in length. 17. The composition of claim 1 , wherein said at least one nucleic acid agent is selected from the group consisting of a double-stranded RNA (dsRNA), an antisense RNA, and a ribozyme. 18. The composition of claim 17 , wherein said dsRNA is selected from the group consisting of a small inhibitory RNA (siRNA), a short-hairpin RNA (shRNA), and a microRNA (miRNA).
against enzymes (viral enzymes C12N15/1131; receptors C12N15/1138) · CPC title
Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title
Double-stranded nucleic acids or oligonucleotides · CPC title
for insects, e.g. bees or silkworms · CPC title
Sugars; Polysaccharides · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.